Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11381111 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
Conditions: Schizophrenia;   Memory Disorders;   Cognition Disorders
Interventions: Drug: Atomoxetine;   Procedure: Functional magnetic resonance imaging;   Procedure: Neuropsychological Testing;   Drug: Placebo

Indicates status has not been verified in more than two years